Jentzsch, T
Acylcarnitines are emerging as key players in the fight against metabolic diseases, serving as diagnostic biomarkers and even potential therapeutic targets
Proc Natl Acad Sci USA 112(1):E2129 Li J, Li X, Wu L, Pei M, Li H, Jiang Y (2019b) miR-145 inhibits glutamine metabolism through c-myc/GLS1 pathways in ovarian cancer cells
Cagrilintide combinations The emerging cagrilintide and tirzepatide combination represents a different approach to multi-receptor targeting
Aberrant and diseased astrocytes promote death of motor neurones in amyotrophic lateral sclerosis, whereas loss of astrocyte homoeostatic support contributes to neuronal malfunction and demise in AD, PD, and HD
ROS also enhance their proliferation via two mechanisms: either by damaging biological molecules, leading to gene mutation and inflammation, or through abnormal oxidative stress redox signaling, which distorts signaling pathways and drives cancer progression